FGFR2 and breast carcinoma: To determine whether the identified breast cancer mutation is primarily mediated by the FGFR2-IIIb or FGFR2-IIIc isoform, we examined the presence of the IIIb and IIIc transcripts in three cDNA samples synthesized from tumor tissue total RNAs of sporadic breast cancer patients.